TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for WT1
check button Gene summary
Basic gene informationGene symbolWT1
Gene nameWilms tumor 1
SynonymsAWT1|EWS-WT1|GUD|NPHS4|WAGR|WIT-2|WT33
CytomapUCSC genome browser: 11p13
Type of geneprotein-coding
RefGenesNM_000378.4,
NM_001198551.1,NM_001198552.1,NM_024424.3,NM_024426.4,
NM_024425.2,
DescriptionWilms tumor proteinamino-terminal domain of EWSlast three zinc fingers of the DNA-binding domain of WT1
Modification date20141222
dbXrefs MIM : 607102
HGNC : HGNC
Ensembl : ENSG00000184937
HPRD : 06163
Vega : OTTHUMG00000039556
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_WT1
BioGPS: 7490
PathwayNCI Pathway Interaction Database: WT1
KEGG: WT1
REACTOME: WT1
Pathway Commons: WT1
ContextiHOP: WT1
ligand binding site mutation search in PubMed: WT1
UCL Cancer Institute: WT1
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesTiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)OvaryUterus
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)OVUCEC,UCS
Reference showing the relevant tissue of WT1
Description by TissGene annotationsCancer gene
TissgsKTS
CNV lost TissGeneKTS
Fused withOncogene
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID
GO:0000122negative regulation of transcription from RNA polymerase II promoter7585606
GO:0007530sex determination9815658
GO:0008285negative regulation of cell proliferation9553041
GO:0017148negative regulation of translation7588596
GO:0030308negative regulation of cell growth7588596
GO:0043065positive regulation of apoptotic process7588596
GO:0045892negative regulation of transcription, DNA-templated12802290
GO:0045893positive regulation of transcription, DNA-templated12802290
GO:0045893positive regulation of transcription, DNA-templated9815658
GO:0071371cellular response to gonadotropin stimulus15961562
GO:0000122negative regulation of transcription from RNA polymerase II promoter7585606
GO:0007530sex determination9815658
GO:0008285negative regulation of cell proliferation9553041
GO:0017148negative regulation of translation7588596
GO:0030308negative regulation of cell growth7588596
GO:0043065positive regulation of apoptotic process7588596
GO:0045892negative regulation of transcription, DNA-templated12802290
GO:0045893positive regulation of transcription, DNA-templated12802290
GO:0045893positive regulation of transcription, DNA-templated9815658
GO:0071371cellular response to gonadotropin stimulus15961562


Top
TissGeneExp for WT1

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
COAD-0.073708576-3.6026816533.5289730771.35E-079.30E-07
HNSC-2.430094622-4.053785321.6236906981.23E-056.83E-05
KICH-4.0160525762.759727424-6.775785.03E-136.31E-12
KIRC0.4354400353.301990035-2.866551.88E-096.11E-09
BRCA0.127550196-3.18738843.3149385962.92E-232.61E-22
KIRP-1.8666835763.549069549-5.4157531258.55E-152.20E-13
LUAD-0.822999955-1.8679327141.0449327590.01080.019164873
STAD-2.267455451-3.5740929511.30663750.00360.014938007
LUSC0.110120836-1.2329752431.3430960780.004660.00785503


Top
TissGene-miRNA for WT1

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for WT1
TissGeneSNV for WT1

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.D342NSKCM2
p.R250QCOAD2
p.G246DSKCM1
p.S233LGBM1
p.H473YLUAD1
p.S461FLUAD1
p.S112NREAD1
p.S435PLIHC1
p.P450QESCA1
p.W328*SKCM1
p.Q437HACC1
p.S138YLUAD1
p.P185HTHYM1
p.N293KSTAD1
p.K316NESCA1
p.R176CBLCA1
p.S461YLUAD1
p.P420RLIHC1
p.R430QSKCM1
p.M297ICESC1
p.R434HBRCA1
p.P136THNSC1
p.R501HUCEC1
p.R189KCOAD1
p.R380WUCEC1
p.R434CSKCM1
p.M297ISKCM1
p.L315SSKCM1
p.P197HTHYM1
p.R443STHCA1
p.D342YLUAD1
p.R389CACC1
p.Q422KLUAD1
p.R369*HNSC1
p.R462LLUAD1
p.G475DSKCM1
p.H465YLAML1
p.Q437LBLCA1
p.R222CSKCM1
p.R462WLAML1
p.T314ISKCM1
p.E153KLUAD1
p.N198YSKCM1
p.T146MCOAD1
p.T298ILUAD1
p.K316TLUSC1
p.T385SKIRC1
p.G447VLUAD1
p.R462LHNSC1
p.Q225HACC1
p.G229CLUAD1
p.Q452*SKCM1
p.R501CBRCA1
p.R213LESCA1
p.S186RLUSC1
p.G178RCESC1
p.S336NLGG1
p.P481SSKCM1
p.M309ISKCM1
p.T346MLIHC1
p.D3NLIHC1
p.T477KLUAD1
p.T102ISKCM1
p.Y354NKIRC1
p.D282NSKCM1
p.R462LUCEC1
p.G4SLIHC1
p.D497NSKCM1
p.R458*GBM1
p.D427YLUAD1
p.R458*PRAD1
p.H242NPCPG1
p.P200SSKCM1
p.K439QSTAD1
p.F239LLUSC1
p.D275NSTAD1
p.P450QLUAD1
p.S165FESCA1
p.K480NPRAD1
p.M250LLIHC1
p.D130NSKCM1
p.W116XSKCM1
p.T346MESCA1
p.P179LREAD1
p.E384KBLCA1
p.Y354DLUSC1
p.R222HCOAD1
p.Q240XSKCM1
p.L103SSKCM1
p.K459TSTAD1


Top
TissGeneCNV for WT1

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for WT1

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
Chimerdb3.0ChiTaRsNAS79672EWSR1-WT1chr22:29683128chr11:32414261
Chimerdb3.0ChiTaRsdesmoplastic small round cell tumorS74529EWSR1-WT1chr22:29683128chr11:32410699


Top
TissGeneNet for WT1

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
WT1, TP63, MDM2, GATA2, EGR1, PRKACA, TP73, CIAO1, UBE2I, PAWR, ZNF205, WTAP, EZH2, GATA1, SUZ12, DNMT1, AREG, FHL2, PDGFA, NPM3, IGF2 (tumor)WT1, TP63, MDM2, GATA2, MEN1, CREBBP, PRKACA, TP73, CIAO1, ZNF205, WTAP, EZH2, GATA1, DNMT1, FHL2, PDGFA, NPM3, U2AF2, DVL3, TAOK1, PAX2 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
WT1, TP53, TP63, MDM2, MEN1, EGR1, PRKACA, TP73, CIAO1, UBE2I, PAWR, EZH2, GATA1, SUZ12, DNMT1, AREG, U2AF2, DVL3, TAOK1, IGF2, PAX2 (tumor)WT1, TP53, MDM2, GATA2, CREBBP, EGR1, PRKACA, TP73, CIAO1, WTAP, GATA1, SUZ12, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, DVL3, TAOK1, PAX2 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
WT1, TP53, TP63, GATA2, MEN1, CREBBP, TP73, CIAO1, PAWR, ZNF205, WTAP, EZH2, SUZ12, DNMT1, FHL2, PDGFA, U2AF2, DVL3, TAOK1, IGF2, PAX2 (tumor)WT1, TP63, MDM2, GATA2, MEN1, CREBBP, EGR1, PRKACA, TP73, CIAO1, UBE2I, ZNF205, WTAP, EZH2, AREG, FHL2, PDGFA, DVL3, TAOK1, IGF2, PAX2 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
WT1, TP63, MDM2, GATA2, EGR1, PRKACA, TP73, PAWR, ZNF205, EZH2, SUZ12, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, DVL3, TAOK1, IGF2, PAX2 (tumor)WT1, TP53, TP63, MDM2, GATA2, EGR1, PRKACA, CIAO1, UBE2I, PAWR, ZNF205, WTAP, SUZ12, DNMT1, AREG, FHL2, PDGFA, DVL3, TAOK1, IGF2, PAX2 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
WT1, TP53, TP63, MDM2, GATA2, CREBBP, EGR1, PRKACA, CIAO1, UBE2I, ZNF205, WTAP, GATA1, DNMT1, FHL2, PDGFA, U2AF2, DVL3, TAOK1, IGF2, PAX2 (tumor)WT1, TP53, TP63, MDM2, GATA2, CREBBP, PRKACA, TP73, CIAO1, UBE2I, PAWR, EZH2, SUZ12, DNMT1, FHL2, PDGFA, NPM3, U2AF2, DVL3, IGF2, PAX2 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
WT1, TP63, MDM2, GATA2, MEN1, CREBBP, PRKACA, TP73, UBE2I, PAWR, WTAP, EZH2, SUZ12, DNMT1, FHL2, PDGFA, U2AF2, DVL3, TAOK1, IGF2, PAX2 (tumor)WT1, TP53, TP63, GATA2, CREBBP, TP73, CIAO1, PAWR, ZNF205, WTAP, EZH2, GATA1, SUZ12, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, IGF2, PAX2 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
WT1, TP53, GATA2, MEN1, EGR1, PRKACA, TP73, CIAO1, UBE2I, PAWR, WTAP, EZH2, GATA1, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, DVL3, IGF2 (tumor)WT1, TP53, TP63, GATA2, MEN1, EGR1, TP73, CIAO1, UBE2I, WTAP, EZH2, SUZ12, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, DVL3, IGF2, PAX2 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
WT1, TP53, MDM2, GATA2, MEN1, CREBBP, EGR1, PRKACA, TP73, UBE2I, PAWR, ZNF205, EZH2, SUZ12, FHL2, PDGFA, NPM3, DVL3, TAOK1, IGF2, PAX2 (tumor)WT1, MDM2, GATA2, MEN1, PRKACA, CIAO1, PAWR, ZNF205, WTAP, EZH2, GATA1, SUZ12, DNMT1, AREG, FHL2, PDGFA, U2AF2, DVL3, TAOK1, IGF2, PAX2 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
WT1, TP53, TP63, CREBBP, EGR1, PRKACA, TP73, UBE2I, PAWR, WTAP, EZH2, SUZ12, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, DVL3, TAOK1, IGF2 (tumor)WT1, TP63, GATA2, MEN1, CREBBP, EGR1, PRKACA, TP73, UBE2I, ZNF205, EZH2, GATA1, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, TAOK1, IGF2, PAX2 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
WT1, TP53, GATA2, MEN1, PRKACA, TP73, CIAO1, UBE2I, PAWR, ZNF205, WTAP, EZH2, GATA1, AREG, FHL2, PDGFA, NPM3, U2AF2, DVL3, TAOK1, PAX2 (tumor)WT1, TP53, TP63, GATA2, MEN1, CREBBP, EGR1, PRKACA, TP73, UBE2I, PAWR, ZNF205, EZH2, GATA1, SUZ12, FHL2, PDGFA, NPM3, DVL3, TAOK1, PAX2 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
WT1, TP53, GATA2, MEN1, CREBBP, EGR1, PRKACA, TP73, PAWR, EZH2, GATA1, SUZ12, DNMT1, AREG, PDGFA, NPM3, U2AF2, DVL3, TAOK1, IGF2, PAX2 (tumor)WT1, TP63, MDM2, GATA2, MEN1, CREBBP, EGR1, PRKACA, TP73, CIAO1, UBE2I, WTAP, EZH2, GATA1, DNMT1, AREG, FHL2, PDGFA, DVL3, IGF2, PAX2 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
WT1, TP53, TP63, MDM2, MEN1, CREBBP, EGR1, PRKACA, TP73, CIAO1, UBE2I, WTAP, EZH2, GATA1, DNMT1, AREG, FHL2, PDGFA, NPM3, DVL3, TAOK1 (tumor)WT1, TP53, TP63, MEN1, PRKACA, TP73, UBE2I, ZNF205, WTAP, EZH2, GATA1, SUZ12, DNMT1, AREG, FHL2, PDGFA, NPM3, U2AF2, DVL3, TAOK1, IGF2 (normal)
bullet pointbullet point


Top
TissGeneProg for WT1

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for WT1
TissGeneDrug for WT1

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for WT1

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0027708Nephroblastoma220BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT
umls:C0023467Leukemia, Myelocytic, Acute62BeFree,CTD_human,GAD,LHGDN
umls:C0023418leukemia49BeFree,CTD_human,LHGDN
umls:C0950121Denys-Drash Syndrome43BeFree,CLINVAR,CTD_human,GAD,LHGDN,MGD,ORPHANET,UNIPROT
umls:C0281508Desmoplastic Small Round Cell Tumor38BeFree,ORPHANET
umls:C0596263Carcinogenesis25BeFree
umls:C0025362Mental Retardation22BeFree
umls:C0242596Neoplasm, Residual19BeFree
umls:C0950122Frasier Syndrome19BeFree,CLINVAR,CTD_human,LHGDN,ORPHANET,UNIPROT
umls:C0085669Acute leukemia18BeFree
umls:C0023473Myeloid Leukemia, Chronic15BeFree,CTD_human,GAD
umls:C0206115WAGR Syndrome14BeFree,CTD_human,GAD,ORPHANET
umls:C0006142Malignant neoplasm of breast12BeFree
umls:C0027726Nephrotic Syndrome12BeFree,GAD,LHGDN
umls:C0678222Breast Carcinoma12BeFree
umls:C0280100Solid tumour10BeFree
umls:C1458155Mammary Neoplasms10BeFree,CTD_human,LHGDN
umls:C1511789Desmoplastic10BeFree
umls:C0022665Kidney Neoplasm9BeFree,GAD
umls:C0023449Acute lymphocytic leukemia9BeFree
umls:C1261473Sarcoma9BeFree,LHGDN
umls:C3839868Cytogenetically normal acute myeloid leukemia9BeFree
umls:C0003076Aniridia8BeFree
umls:C0023470Myeloid Leukemia8BeFree,GAD
umls:C0000768Congenital Abnormality7BeFree
umls:C0220621pediatric acute myeloblastic leukemia7BeFree
umls:C0403397Steroid-resistant nephrotic syndrome7BeFree
umls:C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma7BeFree,LHGDN
umls:C0018051Gonadal Dysgenesis6BeFree
umls:C0025500Mesothelioma6BeFree,CLINVAR,LHGDN
umls:C0041408Turner Syndrome6BeFree
umls:C0598766Leukemogenesis6BeFree
umls:C0005699Blast Phase5BeFree
umls:C0017636Glioblastoma5BeFree,CTD_human,LHGDN
umls:C0017638Glioma5BeFree,LHGDN
umls:C0017668Focal glomerulosclerosis5BeFree,GAD,LHGDN
umls:C0042063Urogenital Abnormalities5BeFree
umls:C2239176Liver carcinoma5BeFree,LHGDN
umls:C0007137Squamous cell carcinoma4BeFree,LHGDN
umls:C0022658Kidney Diseases4BeFree
umls:C0024299Lymphoma4BeFree,LHGDN
umls:C0029463Osteosarcoma4BeFree,LHGDN
umls:C0206661Gonadoblastoma4BeFree
umls:C0242379Malignant neoplasm of lung4BeFree
umls:C1840451MULTICYSTIC RENAL DYSPLASIA, BILATERAL4BeFree
umls:C2930471Bilateral Wilms Tumor4BeFree
umls:C3151568NEPHROTIC SYNDROME, TYPE 44CTD_human,UNIPROT
umls:C0007131Non-Small Cell Lung Carcinoma3BeFree
umls:C0022661Kidney Failure, Chronic3BeFree,GAD
umls:C0025202melanoma3BeFree,LHGDN
umls:C0027627Neoplasm Metastasis3LHGDN
umls:C0028754Obesity3BeFree
umls:C0029925Ovarian Carcinoma3BeFree
umls:C0178664Glomerulosclerosis (disorder)3BeFree
umls:C0268731Renal glomerular disease3BeFree
umls:C0279702Conventional (Clear Cell) Renal Cell Carcinoma3BeFree
umls:C0333497Segmental glomerulosclerosis3BeFree
umls:C0555198Malignant Glioma3BeFree
umls:C0677886Epithelial ovarian cancer3BeFree
umls:C0684249Carcinoma of lung3BeFree
umls:C0848558Hypospadias3BeFree,GAD
umls:C0919267ovarian neoplasm3BeFree,LHGDN
umls:C0001418Adenocarcinoma2BeFree,LHGDN
umls:C0008626Congenital chromosomal disease2BeFree
umls:C0009402Colorectal Carcinoma2BeFree
umls:C0010417Cryptorchidism2BeFree
umls:C0014170Endometrial Neoplasms2LHGDN
umls:C0017658Glomerulonephritis2CTD_human,LHGDN
umls:C0018916Hemangioma2BeFree
umls:C0019284Diaphragmatic Hernia2BeFree,CTD_human
umls:C0020502Hyperparathyroidism2BeFree,LHGDN
umls:C0023448Lymphoid leukemia2BeFree
umls:C0023452Leukemia, Lymphocytic, Acute, L12BeFree
umls:C0023903Liver neoplasms2BeFree
umls:C0024623Malignant neoplasm of stomach2BeFree
umls:C0030297Pancreatic Neoplasm2CTD_human,GAD
umls:C0033027Preleukemia2BeFree,GAD
umls:C0035078Kidney Failure2BeFree
umls:C0035335Retinoblastoma2BeFree
umls:C0158687Congenital malformation of genital organs2BeFree
umls:C0178874Tumor Progression2BeFree
umls:C0206655Alveolar rhabdomyosarcoma2BeFree
umls:C0206658Smooth Muscle Tumor2LHGDN
umls:C0220615Adult Acute Myeloblastic Leukemia2BeFree
umls:C0235833Congenital diaphragmatic hernia2BeFree,CTD_human
umls:C0268747Diffuse mesangial sclerosis (disorder)2BeFree,CLINVAR,GAD
umls:C0345967Malignant mesothelioma2BeFree
umls:C0376358Malignant neoplasm of prostate2BeFree
umls:C0376545Hematologic Neoplasms2BeFree
umls:C0431663Bilateral Cryptorchidism2BeFree
umls:C0585442Osteosarcoma of bone2BeFree
umls:C0699791Stomach Carcinoma2BeFree
umls:C0740457Malignant neoplasm of kidney2BeFree
umls:C0751606Adult Acute Lymphocytic Leukemia2BeFree
umls:C1140680Malignant neoplasm of ovary2BeFree
umls:C1320468Nephrogenic rest2BeFree
umls:C1378703Renal carcinoma2BeFree
umls:C1527249Colorectal Cancer2BeFree
umls:C1540912Hypereosinophilic syndrome2BeFree,LHGDN
umls:C1621958Glioblastoma Multiforme2BeFree
umls:C1691215Penile hypospadias2BeFree
umls:C1837026MEACHAM SYNDROME (disorder)2CLINVAR,ORPHANET,UNIPROT
umls:C1961099Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2BeFree
umls:C0001430Adenoma1BeFree
umls:C0002395Alzheimer's Disease1GAD,LHGDN
umls:C0002793Anaplasia1BeFree
umls:C0004352Autistic Disorder1BeFree
umls:C0004903Beckwith-Wiedemann Syndrome1BeFree
umls:C0007095Carcinoid Tumor1LHGDN
umls:C0007102Malignant tumor of colon1BeFree
umls:C0007115Malignant neoplasm of thyroid1BeFree
umls:C0007134Renal Cell Carcinoma1BeFree
umls:C0009375Colonic Neoplasms1CTD_human
umls:C0011881Diabetic Nephropathy1BeFree
umls:C0013080Down Syndrome1BeFree
umls:C0014175Endometriosis1BeFree
umls:C0014457Eosinophilia1BeFree
umls:C0015397Disorder of eye1GAD
umls:C0015625Fanconi Anemia1BeFree
umls:C0016059Fibrosis1LHGDN
umls:C0018923Hemangiosarcoma1BeFree
umls:C0018939Hematological Disease1BeFree
umls:C0019693HIV Infections1BeFree
umls:C0020538Hypertensive disease1BeFree
umls:C0021364Male infertility1BeFree
umls:C0023269leiomyosarcoma1BeFree
umls:C0023439Leukemia, Eosinophilic, Acute1BeFree
umls:C0023480Leukemia, Myelomonocytic, Chronic1GAD
umls:C0023895Liver diseases1BeFree
umls:C0024121Lung Neoplasms1CTD_human
umls:C0025149Medulloblastoma1LHGDN
umls:C0025286Meningioma1BeFree
umls:C0026985Myelodysplasia1BeFree
umls:C0027686Pathologic Neovascularization1GAD
umls:C0027809Neurilemmoma1CTD_human
umls:C0033804Pseudohermaphroditism1BeFree
umls:C0034069Pulmonary Fibrosis1BeFree
umls:C0035412Rhabdomyosarcoma1BeFree
umls:C0036429Sclerosis1LHGDN
umls:C0036769Sertoli Cell Tumor1LHGDN
umls:C0040136Thyroid Neoplasm1LHGDN
umls:C0040336Tobacco Use Disorder1GAD
umls:C0079218Fibromatosis, Aggressive1BeFree,LHGDN
umls:C0085183Neoplasms, Second Primary1GAD
umls:C0085215Ovarian Failure, Premature1CTD_human
umls:C0152013Adenocarcinoma of lung (disorder)1BeFree
umls:C0153594Malignant neoplasm of testis1BeFree
umls:C0153676Secondary malignant neoplasm of lung1BeFree
umls:C0158570Vascular anomaly1BeFree
umls:C0205647Follicular adenoma1BeFree
umls:C0205851Germ cell tumor1BeFree
umls:C0206141Idiopathic Hypereosinophilic Syndrome1BeFree
umls:C0206663Neuroectodermal Tumor, Primitive1BeFree
umls:C0206724Sex Cord-Stromal Tumor1BeFree
umls:C0220810Congenital defects1BeFree
umls:C0235974Pancreatic carcinoma1BeFree
umls:C0238198Gastrointestinal Stromal Tumors1LHGDN
umls:C0239179Defect of diaphragm1BeFree
umls:C0242404Myofibroblastoma1BeFree
umls:C0263662Disseminated eosinophilic collagen disease1BeFree
umls:C0263666Dermatomyositis, Childhood Type1BeFree
umls:C0278883Metastatic melanoma1BeFree
umls:C0279000Liver and Intrahepatic Biliary Tract Carcinoma1BeFree
umls:C0279980Extraosseous Ewings sarcoma-primitive neuroepithelial tumor1BeFree
umls:C0280324Laryngeal Squamous Cell Carcinoma1BeFree
umls:C0334121Inflammatory Myofibroblastic Tumor1BeFree
umls:C0334463Malignant Fibrous Histiocytoma1BeFree
umls:C0334513Sarcomatoid Mesothelioma1BeFree
umls:C0334695Endometrial Stromal Tumors1LHGDN
umls:C0345904Malignant neoplasm of liver1BeFree
umls:C0346109Malignant Mesothelioma of Peritoneum1BeFree
umls:C0346421Chronic eosinophilic leukemia1BeFree
umls:C0346647Malignant neoplasm of pancreas1BeFree
umls:C0346976Secondary malignant neoplasm of pancreas1BeFree
umls:C0376544Hematopoietic Neoplasms1BeFree
umls:C0432412Chromosome 8, trisomy1BeFree
umls:C0520679Sleep Apnea, Obstructive1BeFree
umls:C0549473Thyroid carcinoma1BeFree
umls:C0600139Prostate carcinoma1BeFree
umls:C0684337Ewings sarcoma-primitive neuroectodermal tumor (PNET)1BeFree
umls:C0699790Colon Carcinoma1BeFree
umls:C0751356Idiopathic Inflammatory Myopathies1BeFree
umls:C0855197Testicular malignant germ cell tumor1BeFree
umls:C0856742Post MI1BeFree
umls:C0862312Epithelioid mesothelioma, malignant1BeFree
umls:C1168401Squamous cell carcinoma of the head and neck1BeFree
umls:C1275278Extraskeletal Myxoid Chondrosarcoma1BeFree
umls:C1292769Precursor B-cell lymphoblastic leukemia1BeFree
umls:C1306571Hepatic Insufficiency1LHGDN
umls:C1306759Eosinophilic disorder1BeFree
umls:C1319315Adenocarcinoma of large intestine1BeFree
umls:C1333003Childhood Renal Neoplasm1BeFree
umls:C1334630Malignant Vascular Neoplasm1BeFree
umls:C1334699Mesenchymal Cell Neoplasm1BeFree
umls:C1335302Pancreatic Ductal Adenocarcinoma1BeFree
umls:C1335976Skull Base Meningioma1BeFree
umls:C1336052Spindle Cell Neoplasm1BeFree
umls:C1510586Autism Spectrum Disorders1BeFree
umls:C1559271Non-Malignant Ascites Adverse Event1BeFree
umls:C1636667Disorder characterized by eosinophilia1BeFree
umls:C1762616Meningioma, benign, no ICD-O subtype1BeFree
umls:C1834582MYELOPROLIFERATIVE SYNDROME, TRANSIENT1BeFree
umls:C2316810Chronic kidney disease stage 51BeFree
umls:C275182446, XY Disorders of Sex Development1BeFree
umls:C2826025Mixed phenotype acute leukemia1BeFree
umls:C2931785Juvenile dermatomyositis1BeFree
umls:C2939461Myeloid neoplasm1BeFree
umls:C3463824MYELODYSPLASTIC SYNDROME1GAD
umls:C3469521FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)1BeFree
umls:C3539878Triple Negative Breast Neoplasms1BeFree
umls:C2931752Meacham Winn Culler syndrome0CTD_human
umls:C2931803Deletion 11p130ORPHANET